CompletedPhase 2

A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD

NCT05414422

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Preferred Research Partners

Little Rock, Arkansas, United States

+20 additional locations

Save this trial

Preferred Research PartnersLittle Rock, Arkansas, United States
CNS NetworkGarden Grove, California, United States
Kadima Neuropsychiatry InstituteLa Jolla, California, United States
Synergy San DiegoLemon Grove, California, United States
NRC Research InstituteOrange, California, United States
Premier Clinical Research Institute Inc.Miami, Florida, United States
Psych AtlantaMarietta, Georgia, United States
Hassman Research InstituteBerlin, New Jersey, United States
Princeton Medical InstitutePrinceton, New Jersey, United States
Midwest Clinical Research CenterDayton, Ohio, United States
Neuro-Behavioral Clinical ResearchNorth Canton, Ohio, United States
Insite Clinical Research LLC; Inpatient facility name: SerenityDeSoto, Texas, United States
Pillar Clinical Research, LLCRichardson, Texas, United States
Klinikum der Johann Wolfgang Goethe-UniversitaetFrankfurt, Germany
Pharmakologisches Studienzentrum Chemnitz GmbHMittweida, Germany
Somni bene GmbHSchwerin, Germany
Universitaetsklinikum WuerzburgWürzburg, Germany
Indywidualna Specjalistyczna Praktyka LekarskaGdansk, Poland
Centrum Badan Klinicznych PI-House sp. z o.o.Gdansk, Poland
Wojewodzki Szpital Dla Nerwowo i Psychicznie ChorychGmina Świecie, Poland
Prywatny Gabinet Lekarski Jaroslaw StrzelecTuszyn, Poland